GWSG
BIO icon

GPS Wealth Strategies Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

GPS Wealth Strategies Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-26
Closed -$15K – 1107
2022
Q1 		$15K Hold
26
– – ﹤0.01% 637
2021
Q4 		$20K Hold
26
– – ﹤0.01% 580
2021
Q3 		$20K Hold
26
– – 0.01% 559
2021
Q2 		$17K Buy
+26
New +$15.8K ﹤0.01% 621

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

GPS Wealth Strategies Group's BIO Position: Q2 2022 in Review

GPS Wealth Strategies Group sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2022, closing a stake of 26 shares — an estimated $15K sold.

GPS Wealth Strategies Group first reported a position in BIO in Q2 2021 and held it in 4 quarters. The position peaked at $20K in Q4 2021. 500 funds tracked by Wall St. Rank hold BIO as of Q2 2022.

  • GPS Wealth Strategies Group reported no remaining Bio-Rad Laboratories Class A position as of Q2 2022 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 26 Bio-Rad Laboratories Class A shares in Q2 2022, an estimated $15K.
  • GPS Wealth Strategies Group first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and held it in 4 quarters.
  • GPS Wealth Strategies Group's Bio-Rad Laboratories Class A position peaked at $20K in Q4 2021.
  • 500 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2022.

Based on GPS Wealth Strategies Group's 13F filing for Q2 2022, filed 19 Jul 2022.